Melatonin attenuates inflammatory response-induced brain edema in early brain injury following a subarachnoid hemorrhage: A possible role for the regulation of pro-inflammatory cytokines

Journal of Pineal Research

Volumn 57, Issue 3, 2014, Pages 340-347

  Chen, Jingyin ^a   Chen, Gao ^a   Li, Jianru ^a   Qian, Cong ^a   Mo, Hangbo ^a   Gu, Chi ^a   Yan, Feng ^a   Yan, Wei ^a   Wang, Lin ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

blood brain barrier; brain edema; early brain injury; inflammation; melatonin; subarachnoid hemorrhage

Indexed keywords

CARBON DIOXIDE; CLAUDIN 5; EVANS BLUE; GELATINASE A; GELATINASE B; GLUCOSE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MELATONIN; OCCLUDIN; OXYGEN; PROTEIN ZO1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; WATER; AUTACOID; CYTOKINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PH; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CIRCULUS ARTERIOSUS; BRAIN EDEMA; BRAIN INJURY; BRAIN WATER; CARBON DIOXIDE TENSION; CONTROLLED STUDY; CYTOKINE RESPONSE; DRUG MECHANISM; EARLY BRAIN INJURY; EXTRAVASATION; GLUCOSE BLOOD LEVEL; IMMUNOLOCALIZATION; LEFT HEMISPHERE; MALE; MEAN ARTERIAL PRESSURE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OXYGEN TENSION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; RIGHT HEMISPHERE; SHAM PROCEDURE; SPRAGUE DAWLEY RAT; SUBARACHNOID HEMORRHAGE; WESTERN BLOTTING; ZYMOGRAPHY; ANIMAL; COMPLICATION; METABOLISM;

ANIMALS; BRAIN EDEMA; BRAIN INJURIES; CYTOKINES; INFLAMMATION MEDIATORS; MALE; MELATONIN; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE;

EID: 84925306989     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12173     Document Type: Article

References (55)

1. Bederson JB, Connolly ES Jr, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009; 40: 994-1025.
2. Cahill J, Zhang JH,. Subarachnoid hemorrhage: is it time for a new direction? Stroke 2009; 40: S86-S87.
3. Altay O, Suzuki H, Hasegawa Y, et al. Isoflurane attenuates blood-brain barrier disruption in ipsilateral hemisphere after subarachnoid hemorrhage in mice. Stroke 2012; 43: 2513-2516.
4. Westermaier T, Stetter C, Raslan F, et al. Brain edema formation correlates with perfusion deficit during the first six hours after experimental subarachnoid hemorrhage in rats. Exp Transl Stroke Med 2012; 4: 8.
5. Claassen J, Carhuapoma JR, Kreiter KT, et al. Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke 2002; 33: 1225-1232.
6. Keep RF, Andjelkovic AV, Stamatovic SM, et al. Ischemia-induced endothelial cell dysfunction. Acta Neurochir Suppl 2005; 95: 399-402.
7. Sehba FA, Friedrich V Jr, Makonnen G, et al. Acute cerebral vascular injury after subarachnoid hemorrhage and its prevention by administration of a nitric oxide donor. J Neurosurg 2007; 106: 321-329.
8. Ostrowski RP, Colohan AR, Zhang JH,. Molecular mechanisms of early brain injury after subarachnoid hemorrhage. Neurol Res 2006; 28: 399-414.
9. Sercombe R, Dinh YR, Gomis P,. Cerebrovascular inflammation following subarachnoid hemorrhage. Jpn J Pharmacol 2002; 88: 227-249.
10. McKeating EG, Andrews PJ,. Cytokines and adhesion molecules in acute brain injury. Br J Anaesth 1998; 80: 77-84.
11. Nag S, Manias JL, Stewart DJ,. Pathology and new players in the pathogenesis of brain edema. Acta Neuropathol 2009; 118: 197-217.
12. Yang Y, Estrada EY, Thompson JF, et al. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 2007; 27: 697-709.
13. Gaetani P, Tartara F, Pignatti P, et al. Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol Res 1998; 20: 337-342.
14. Greenhalgh AD, Brough D, Robinson EM, et al. Interleukin-1 receptor antagonist is beneficial after subarachnoid haemorrhage in rat by blocking haem-driven inflammatory pathology. Dis Model Mech 2012; 5: 823-833.
15. Larysz-Brysz M, Lewin-Kowalik J, Czuba Z, et al. Interleukin-1beta increases release of endothelin-1 and tumor necrosis factor as well as reactive oxygen species by peripheral leukocytes during experimental subarachnoid hemorrhage. Curr Neurovasc Res 2012; 9: 159-166.
16. Fang Q, Chen G, Zhu W, et al. Influence of melatonin on cerebrovascular proinflammatory mediators expression and oxidative stress following subarachnoid hemorrhage in rabbits. Mediators Inflamm 2009; 2009: 426346.
17. Kaur C, Sivakumar V, Robinson R, et al. Neuroprotective effect of melatonin against hypoxia-induced retinal ganglion cell death in neonatal rats. J Pineal Res 2013; 54: 190-206.
18. Galano A, Tan DX, Reiter RJ,. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res 2013; 54: 245-257.
19. Tao RR, Huang JY, Shao XJ, et al. Ischemic injury promotes Keap1 nitration and disturbance of antioxidative responses in endothelial cells: a potential vasoprotective effect of melatonin. J Pineal Res 2013; 54: 271-281.
20. Cheung RT,. The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion. J Pineal Res 2003; 34: 153-160.
21. Cheung RT, Tipoe GL, Tam S, et al. Preclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration. J Pineal Res 2006; 41: 337-343.
22. Ersahin M, Toklu HZ, Cetinel S, et al. Melatonin reduces experimental subarachnoid hemorrhage-induced oxidative brain damage and neurological symptoms. J Pineal Res 2009; 46: 324-332.
23. Chen J, Wang L, Wu C, et al. Melatonin-enhanced autophagy protects against neural apoptosis via a mitochondrial pathway in early brain injury following a subarachnoid hemorrhage. J Pineal Res 2014; 56: 12-19.
24. Wang Z, Wu L, You W, et al. Melatonin alleviates secondary brain damage and neurobehavioral dysfunction after experimental subarachnoid hemorrhage: possible involvement of TLR4-mediated inflammatory pathway. J Pineal Res 2013; 55: 399-408.
25. Pluta RM, Hansen-Schwartz J, Dreier J, et al. Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res 2009; 31: 151-158.
26. Wang Z, Ma C, Meng CJ, et al. Melatonin activates the Nrf2-ARE pathway when it protects against early brain injury in a subarachnoid hemorrhage model. J Pineal Res 2012; 53: 129-137.
27. Ayer RE, Sugawara T, Chen W, et al. Melatonin decreases mortality following severe subarachnoid hemorrhage. J Pineal Res 2008; 44: 197-204.
28. Park S, Yamaguchi M, Zhou C, et al. Neurovascular protection reduces early brain injury after subarachnoid hemorrhage. Stroke 2004; 35: 2412-2417.
29. Sugawara T, Ayer R, Jadhav V, et al. A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model. J Neurosci Methods 2008; 167: 327-334.
30. Garcia JH, Wagner S, Liu KF, et al. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 1995; 26: 627-634; discussion 635.
31. Xi G, Hua Y, Keep RF, et al. Brain edema after intracerebral hemorrhage: the effects of systemic complement depletion. Acta Neurochir Suppl 2002; 81: 253-256.
32. Hawkes SP, Li H, Taniguchi GT,. Zymography and reverse zymography for detecting MMPs and TIMPs. Methods Mol Biol 2010; 622: 257-269.
33. Tsubokawa T, Jadhav V, Solaroglu I, et al. Lecithinized superoxide dismutase improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Stroke 2007; 38: 1057-1062.
34. Broderick JP, Brott TG, Duldner JE, et al. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 1994; 25: 1342-1347.
35. Mauriz JL, Collado PS, Veneroso C, et al. A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives. J Pineal Res 2013; 54: 1-14.
36. Unterberg AW, Stover J, Kress B, et al. Edema and brain trauma. Neuroscience 2004; 129: 1021-1029.
37. Suzuki H, Hasegawa Y, Kanamaru K, et al. Mechanisms of osteopontin-induced stabilization of blood-brain barrier disruption after subarachnoid hemorrhage in rats. Stroke 2010; 41: 1783-1790.
38. Kniesel U, Wolburg H,. Tight junctions of the blood-brain barrier. Cell Mol Neurobiol 2000; 20: 57-76.
39. Liebner S, Kniesel U, Kalbacher H, et al. Correlation of tight junction morphology with the expression of tight junction proteins in blood-brain barrier endothelial cells. Eur J Cell Biol 2000; 79: 707-717.
40. Fanning AS, Jameson BJ, Jesaitis LA, et al. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem 1998; 273: 29745-29753.
41. Mayhan WG,. VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway. Am J Physiol 1999; 276: C1148-C1153.
42. Josko J, Gwozdz B, Hendryk S, et al. Expression of vascular endothelial growth factor (VEGF) in rat brain after subarachnoid haemorrhage and endothelin receptor blockage with BQ-123. Folia Neuropathol 2001; 39: 243-251.
43. Yatsushige H, Ostrowski RP, Tsubokawa T, et al. Role of c-Jun N-terminal kinase in early brain injury after subarachnoid hemorrhage. J Neurosci Res 2007; 85: 1436-1448.
44. Ostrowski RP, Colohan AR, Zhang JH,. Mechanisms of hyperbaric oxygen-induced neuroprotection in a rat model of subarachnoid hemorrhage. J Cereb Blood Flow Metab 2005; 25: 554-571.
45. Kusaka G, Ishikawa M, Nanda A, et al. Signaling pathways for early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2004; 24: 916-925.
46. Wu C, Hu Q, Chen J, et al. Inhibiting HIF-1alpha by 2ME2 ameliorates early brain injury after experimental subarachnoid hemorrhage in rats. Biochem Biophys Res Commun 2013; 437: 469-474.
47. Sozen T, Tsuchiyama R, Hasegawa Y, et al. Role of interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke 2009; 40: 2519-2525.
48. Asahi M, Wang X, Mori T, et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 2001; 21: 7724-7732.
49. Bauer AT, Burgers HF, Rabie T, et al. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab 2010; 30: 837-848.
50. Cunnea P, McMahon J, O'Connell E, et al. Gene expression analysis of the microvascular compartment in multiple sclerosis using laser microdissected blood vessels. Acta Neuropathol 2010; 119: 601-615.
51. Rudra DS, Pal U, Maiti NC, et al. Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site. J Pineal Res 2013; 54: 398-405.
52. Allan SM, Tyrrell PJ, Rothwell NJ,. Interleukin-1 and neuronal injury. Nat Rev Immunol 2005; 5: 629-640.
53. Ryuto M, Ono M, Izumi H, et al. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem 1996; 271: 28220-28228.
54. Tzeng HE, Tsai CH, Chang ZL, et al. Interleukin-6 induces vascular endothelial growth factor expression and promotes angiogenesis through apoptosis signal-regulating kinase 1 in human osteosarcoma. Biochem Pharmacol 2013; 85: 531-540.
55. Chen S, Ma Q, Krafft PR, et al. P2X7R/cryopyrin inflammasome axis inhibition reduces neuroinflammation after SAH. Neurobiol Dis 2013; 58: 296-307.